Gross total resection of glioma with the intraoperative fluorescence-guidance of fluorescein sodium

Bo Chen, Haifeng Wang, Pengfei Ge, Jingwei Zhao, Wenchen Li, Huizi Gu, Guangming Wang, Yinan Luo, Dawei Chen, Bo Chen, Haifeng Wang, Pengfei Ge, Jingwei Zhao, Wenchen Li, Huizi Gu, Guangming Wang, Yinan Luo, Dawei Chen

Abstract

Objective: High dose fluorescein sodium has been utilized for fluorescence-guided tumor resection with conflicting reports on the efficacy of this procedure. The aim of this study was to reevaluate the utility and clinical limitations of using fluorescein sodium for the treatment and resection of glioma brain tumors.

Methods: Patients diagnosed with glioma were divided into two groups with a total of 22 patients enrolled in the study: 1) the study group (n=10), patients that received intravenous injection of fluorescein sodium and 2) the control group (n=12), patients that did not receive injections during surgical resection. Quality of life was evaluated according to Karnofsky Performance Scale (KPS) score and neurological status. Fluorescein sodium was intravenously injected at a dose of 15-20mg/kg of body weight. Glioma resection was evaluated preoperative and postoperatively with enhanced Magnetic Resonance Imaging (MRI).

Results: Significant differences in the gross total resection (GTR) rates were observed between the two patient groups (Fisher's Exact Test p=0.047). Progressive free survival was significantly longer in the study group (Student's T-Test p=0.033) as well as in the GTR group (Student's T-Test p=0.0001) compared to the control and non-GTR groups, respectively. Three patients in the study group and four patients in the control group had transient neurological deterioration. One patient in the control group had permanent hemiplegia.

Conclusion: The intraoperative utility of using fluorescein sodium can significantly increase the GTR rate without obvious deterioration. In addition, we find that it is better to apply the fluorescein sodium in the cases with BBB (blood-brain barrier) disruption, which had been enhanced in preoperative MRI.

Keywords: fluorescein sodium; glioma; gross-total resection; neurosurgery.

Conflict of interest statement

Competing Interests: The authors have declared that no competing interest exists.

Figures

Fig 1
Fig 1
A-B: Tumor tissue was stained by fluorescein sodium presenting deep to light yellow color. C: Normal parenchyma was not stained.
Fig 2
Fig 2
Histology of glioma tissue in study group (HE, original magnification×200). A-C: High grade glioma. D-F: Low grade glioma. A and D: Deep yellow stained region: dense tumor cells, which were significantly atypical, multinuclear, mitosis, with prominent endothelial proliferation; B and E: Light stained region: less dense tumor cells with scattered endothelial proliferation; C and F: Negative stained region: very rare tumor cells without endothelial proliferation.

References

    1. Babu R, Adamson C. Fluorescence-Guided Malignant Glioma Resections. Curr Drug Discov Technol. 2012 [Epub ahead of print]
    1. Shinoda J, Sakai N, Murase S. et al. Selection of eligible patients with supratentorial glioblastoma multiforme for gross total resection. J Neurooncol. 2001;52:161–71.
    1. Stummer W, Reulen HJ, Meinel T. et al. Extent of resection and survival in glioblastoma multiforme: identification of and adjustment for bias. Neurosurgery. 2008;62:564–76.
    1. Tykocki T, Michalik R, Bonicki W. et al. Fluorescence-guided resection of primary and recurrent malignant gliomas with 5-aminolevulinic acid. Preliminary results. Neurol Neurochir Pol. 2012;46:47–51.
    1. Koc K, Anik I, Cabuk B. et al. Fluorescein sodium-guided surgery in glioblastoma multiforme: a prospective evaluation. Br J Neurosurg. 2008;22:99–103.
    1. Kabuto M, Kubota T, Kobayashi H. et al. Experimental and clinical study of detection of glioma at surgery using fluorescent imaging by a surgical microscope after fluorescein administration. Neurol Res. 1997;19:9–16.
    1. Shinoda J, Yano H, Yoshimura S. et al. Fluorescence-guided resection of glioblastoma multiforme by using high-dose fluorescein sodium. Technical note. J Neurosurg. 2003;99:597–603.
    1. Ichioka T, Miyatake S, Asai N. et al. Enhanced detection of malignant glioma xenograft by fluorescein-human serum albumin conjugate. J Neurooncol. 2004;67:47–52.
    1. Kuroiwa T, Kajimoto Y, Ohta T. Development of a fluorescein operative microscope for use during malignant glioma surgery: a technical note and preliminary report. Surg Neurol. 1998;50:41–9.
    1. Buckner JC. Factors influencing survival in high-grade gliomas. Semin Oncol. 2003;30:10–4.
    1. Litofsky NS, Bauer AM, Kasper RS. et al. Image-guided resection of high-grade glioma: patient selection factors and outcome. Neurosurg Focus. 2006;20:E16.
    1. Hammoud MA, Ligon BL, elSouki R. et al. Use of intraoperative ultrasound for localizing tumors and determining the extent of resection: a comparative study with magnetic resonance imaging. J Neurosurg. 1996;84:737–41.
    1. Ritz R, Daniels R, Noell S. et al. Hypericin for visualization of high grade gliomas: first clinical experience. Eur J Surg Oncol. 2012;38:352–60.
    1. Feigl GC, Ritz R, Moraes M. et al. Resection of malignant brain tumors in eloquent cortical areas: a new multimodal approach combining 5-aminolevulinic acid and intraoperative monitoring. J Neurosurg. 2010;113:352–7.
    1. Eljamel MS, Goodman C, Moseley H. ALA and Photofrin fluorescence-guided resection and repetitive PDT in glioblastoma multiforme: a single centre Phase III randomised controlled trial. Lasers Med Sci. 2008;23:361–7.
    1. Willems PW, Taphoorn MJ, Burger H. et al. Effectiveness of neuronavigation in resecting solitary intracerebral contrast-enhancing tumors: a randomized controlled trial. J Neurosurg. 2006;104:360–8.
    1. Moore GE, Peyton WT. et al. The clinical use of fluorescein in neurosurgery; the localization of brain tumors. J Neurosurg. 1948;5:392–8.
    1. Diez Valle R, Tejada Solis S, Idoate Gastearena MA. et al. Surgery guided by 5-aminolevulinic fluorescence in glioblastoma: volumetric analysis of extent of resection in single-center experience. J Neurooncol. 2011;102:105–13.
    1. Stummer W, Novotny A, Stepp H. et al. Fluorescence-guided resection of glioblastoma multiforme by using 5-aminolevulinic acid-induced porphyrins: a prospective study in 52 consecutive patients. J Neurosurg. 2000;93:1003–13.
    1. Okuda T, Kataoka K, Taneda M. Metastatic brain tumor surgery using fluorescein sodium: technical note. Minim Invasive Neurosurg. 2007;50:382–4.
    1. Panciani PP, Fontanella M, Garbossa D. et al. 5-aminolevulinic acid and neuronavigation in high-grade glioma surgery: results of a combined approach. Neurocirugia (Astur) 2012;23:23–8.
    1. Dilek O, Ihsan A, Tulay H. Anaphylactic reaction after fluorescein sodium administration during intracranial surgery. J Clin Neurosci. 2011;18:430–1.
    1. Mineo JF, Bordron A, Baroncini M. et al. Prognosis factors of survival time in patients with glioblastoma multiforme: a multivariate analysis of 340 patients. Acta Neurochir (Wien) 2007;149:245–52.
    1. Freyschlag CF, Smolczyk DR, Janzen E. et al. Prolonged administration of temozolomide in adult patients with anaplastic glioma. Anticancer Res. 2011;31:3873–7.

Source: PubMed

赞助者和合作者

医疗条件

药物干预

3
订阅